Evidence map›Paper›PMID 33664896›Full record

ReviewJournal of arrhythmia2021

The challenge of optimising ablation lesions in catheter ablation of ventricular tachycardia.

Riccardo Proietti, Luca Lichelli, Nicolas Lellouche, Tarvinder Dhanjal

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of arrhythmia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06138873 (Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06138873 narecruitingnot on this mapstarted 2024, after this paper: background citation

Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy (AIM-VT) - a Prospective Single-Blinded, Multicenter Randomized Controlled Trial

TypeinterventionalSponsorRush University Medical CenterRan2024 to 2027Enrolled100ConditionsVentricular Tachycardia, Ischemic CardiomyopathyArmsAblation-index guided ventricular tachycardia ablation, Ventricular tachycardia ablation with no AI-guidance
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Riccardo ProiettiDepartment of Cardiology University Hospital Coventry & Warwickshire NHS Trust Coventry UK.ORCID https://orcid.org/0000-0003-4113-7030
Luca LichelliDepartment of Cardiac, Thoracic, Vascular Sciences University of Padua Padua Italy.ORCID https://orcid.org/0000-0002-0230-0475
Nicolas LelloucheHopital Henri Mondor Albert Chenevier Creteil France.
Tarvinder DhanjalDepartment of Cardiology University Hospital Coventry & Warwickshire NHS Trust Coventry UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiofrequency catheter ablation has become an established treatment for ventricular tachycardia. The exponential increase in procedures has provided further insights into mechanisms causing arrhythmias and identification of ablation targets with the development of new mapping strategies. Since the definition of criteria to identify myocardial dense scar, borderzone and normal myocardium, and the description of isolated late potentials, local abnormal ventricular activity and decrementing evoked potential mapping, substrate-guided ablation has progressively become the method of choice to guide procedures. Accordingly, a wide range of ablation strategies have been developed from scar homogenization to scar dechanneling or core isolation using increasingly complex and precise tools such as multipolar or omnipolar mapping catheters. Despite these advances long-term success rates for VT ablation have remained static and lower in nonischemic than ischemic heart disease because of the more patchy distribution of myocardial scar. Ablation aims to deliver an irreversible loss of cellular excitability by myocardial heating to a temperatures exceeding 50°C. Many indicators of ablation efficacy have been developed such as contact force, impedance drop, force-time integral and ablation index, mostly validated in atrial fibrillation ablation. In ventricular procedures there is limited data and ablation lesion parameters have been scarcely investigated. Since VT arrhythmia recurrence can be related to inadequate RF lesion formation, it seems reasonable to establish robust markers of ablation efficacy.

Indexed as

catheter ablationlong‐term outcomemultipolar mappingomnipolar mappingventricular tachycardia

Identifiers

PMID33664896
PMCPMC7896466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.